Global Biotech Stocks

JBM (Healthcare)

Market Cap: HK$2.4b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

Quantum-Si

Market Cap: US$305.8m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Contineum Therapeutics

Market Cap: US$304.5m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.

Hubei Guangji Pharmaceutical

Market Cap: CN¥2.2b

Manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China.

Zhejiang East Asia Pharmaceutical

Market Cap: CN¥2.2b

Zhejiang East Asia Pharmaceutical Co., Ltd.

Morepen Laboratories

Market Cap: ₹26.8b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Dong-A ST

Market Cap: ₩425.9b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Omeros

Market Cap: US$298.1m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Capricor Therapeutics

Market Cap: US$298.1m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Indoco Remedies

Market Cap: ₹26.4b

Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.

Eurobio Scientific Société anonyme

Market Cap: €253.9m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Alector

Market Cap: US$296.6m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Cipher Pharmaceuticals

Market Cap: CA$405.7m

Operates as a specialty pharmaceutical company in Canada.

Candel Therapeutics

Market Cap: US$289.3m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

AC Immune

Market Cap: US$287.9m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Aardvark Therapeutics

Market Cap: US$287.0m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Vanda Pharmaceuticals

Market Cap: US$285.4m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Neumora Therapeutics

Market Cap: US$281.8m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Panacea Biotec

Market Cap: ₹24.8b

A biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally.

Aurora Cannabis

Market Cap: CA$388.4m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Tectonic Therapeutic

Market Cap: US$275.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Abeona Therapeutics

Market Cap: US$274.9m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Kyverna Therapeutics

Market Cap: US$274.6m

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.

Mayne Pharma Group

Market Cap: AU$419.2m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

TerrAscend

Market Cap: CA$380.8m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Allogene Therapeutics

Market Cap: US$266.3m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Newron Pharmaceuticals

Market Cap: CHF 209.2m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

3-D Matrix

Market Cap: JP¥39.2b

Develops self-assembling peptide technology in Japan and internationally.

Fuji Pharma

Market Cap: JP¥38.4b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Bioneer

Market Cap: ₩360.3b

Operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally.

Forte Biosciences

Market Cap: US$254.1m

Operates as a clinical-stage biopharmaceutical company in the United States.

Adimmune

Market Cap: NT$7.8b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Formosa Laboratories

Market Cap: NT$7.7b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Cellectis

Market Cap: €215.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Zhaoke Ophthalmology

Market Cap: HK$2.0b

An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.

NIBEC

Market Cap: ₩353.4b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.